Biolase, Inc

CIK 811240 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Biolase, Inc.

Recent SEC filings

FiledFormAccession number
Apr 21, 2025SEC STAFF ACTION9999999997-25-001934
Nov 14, 2024SC 13G/A0001193125-24-258823
Nov 14, 2024SC 13G/A0000929638-24-003922
Nov 7, 202410-Q0000950170-24-123472
Oct 8, 20248-K0000950170-24-113566
Oct 1, 20248-K0000950170-24-110801
Sep 6, 202425-NSE0001354457-24-000647
Sep 6, 20248-K0000950170-24-104387
Aug 28, 20248-K0000950170-24-101380
Aug 8, 202410-Q0000950170-24-094086
Aug 8, 20248-K0000950170-24-093908
Jul 22, 20248-K0000950170-24-085003
Jun 18, 20248-K0000950170-24-074580
Jun 3, 2024S-10001213900-24-049123
May 17, 20248-K0000950170-24-061330
May 13, 20248-K0000950170-24-058626
May 13, 202410-Q0000950170-24-058704
May 6, 20248-K0000950170-24-053536
Apr 23, 2024424B40000950170-24-046924
Apr 22, 2024EFFECT9999999995-24-001065
Apr 19, 20248-K0000950170-24-046010
Apr 19, 2024POS AM0000950170-24-046092
Apr 11, 2024POS AM0000950170-24-043757
Apr 4, 2024424B30000950170-24-041413
Apr 2, 2024EFFECT9999999995-24-000830